Gut microbiota: therapeutic targets of ginseng against multiple disorders and ginsenoside transformation

Z Chen, Z Zhang, J Liu, H Qi, J Li, J Chen… - Frontiers in Cellular …, 2022 - frontiersin.org
Panax ginseng, as the king of Chinese herb, has significant therapeutic effects on obesity,
type 2 diabetes mellitus, fatty liver disease, colitis, diarrhea, and many other diseases. This …

Where does a Staphylococcus aureus vaccine stand?

VG Fowler Jr, RA Proctor - Clinical Microbiology and Infection, 2014 - Wiley Online Library
In this review, we examine the current status of S taphylococcus aureus vaccine
development and the prospects for future vaccines. Examination of the clinical trials to date …

Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh

SA Sarker, S Sultana, G Reuteler, D Moine… - …, 2016 - thelancet.com
Background Antibiotic resistance is rising in important bacterial pathogens. Phage therapy
(PT), the use of bacterial viruses infecting the pathogen in a species-specific way, is a …

Review on pathogenicity mechanism of enterotoxigenic Escherichia coli and vaccines against it

A Mirhoseini, J Amani, S Nazarian - Microbial pathogenesis, 2018 - Elsevier
Enterotoxigenic Escherichia coli (ETEC) is the most common cause of diarrhea in children.
Colonization factors (CFs) and LT enterotoxin are the major ETEC candidate vaccines. To …

Enterotoxigenic Escherichia coli Infections

JM Fleckenstein, FM Kuhlmann - Current infectious disease reports, 2019 - Springer
Abstract Purpose of Review Review recent developments pertaining to the epidemiology,
molecular pathogenesis, and sequelae of enterotoxigenic Escherichia coli (ETEC) infections …

Travelers' diarrhea: a clinical review

AKC Leung, AAM Leung, AHC Wong… - Recent patents on …, 2019 - ingentaconnect.com
Background: Travelers' diarrhea is the most common travel-related malady. It affects millions
of international travelers to developing countries annually and can significantly disrupt travel …

Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo …

RH Behrens, JP Cramer, T Jelinek, H Shaw… - The Lancet infectious …, 2014 - thelancet.com
Summary Background Enterotoxigenic Escherichia coli (ETEC) is a major cause of
travellers' diarrhoea. We investigated the efficacy and safety of a skin-patch vaccine …

Vaccine‐Preventable Travel Health Risks: What Is the Evidence—What Are the Gaps?

R Steffen, RH Behrens, DR Hill… - Journal of travel …, 2015 - academic.oup.com
Background Existing travel health guidelines are based on a variety of data with
underpinning evidence ranging from high‐quality randomized controlled trials to best …

Subunit-based mucosal vaccine delivery systems for pulmonary delivery-Are they feasible?

N Marasini, LM Kaminskas - Drug development and industrial …, 2019 - Taylor & Francis
Pulmonary infections are the most common cause of death globally. However, the
development of mucosal vaccines that provide protective immunity against respiratory …

Novel antigens for enterotoxigenic Escherichia coli vaccines

J Fleckenstein, A Sheikh, F Qadri - Expert review of vaccines, 2014 - Taylor & Francis
Enterotoxigenic Escherichia coli (ETEC) are the most common bacterial pathogens causing
diarrhea in developing countries where they lead to hundreds of thousands of deaths …